Ebola glycoprotein mutant GP-A82V arose early and dominated the West African epidemic
GP-A82V infects human cells more efficiently than does the ancestral glycoprotein
The increased infectivity of GP-A82V is specific for primate cells
GP-A82V was weakly associated with increased mortality during the epidemic